{"id":40295,"date":"2026-04-23T21:05:32","date_gmt":"2026-04-23T21:05:32","guid":{"rendered":"https:\/\/www.europesays.com\/people\/40295\/"},"modified":"2026-04-23T21:05:32","modified_gmt":"2026-04-23T21:05:32","slug":"trump-administration-moves-to-ease-medical-marijuana-rules","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/people\/40295\/","title":{"rendered":"Trump Administration Moves to Ease Medical Marijuana Rules"},"content":{"rendered":"<p>Order would shift cannabis to a lower-risk classification, expand research and provide tax relief for licensed operators<\/p>\n<p><a rel=\"noopener noreferrer nofollow\" target=\"_blank\" href=\"https:\/\/ktla.com\/news\/trump-administration-reclassifies-state-licensed-medical-marijuana\/\">KTLA5<\/a> stated that  Acting Attorney General Todd Blanche signed an order Thursday to reclassify state-licensed medical marijuana as a less dangerous drug, a move that would loosen federal restrictions and offer tax relief to licensed operators.<\/p>\n<p>The change would shift medical marijuana out of one of the most tightly regulated federal categories into a less restrictive classification. While the order does not legalize marijuana at the federal level, it is expected to affect the 40 states that currently allow medical marijuana use.<\/p>\n<p>Blanche said in a post on X that the order calls for an \u201cexpedited hearing\u201d to move marijuana and state-licensed cannabis products, including those approved by the Food and Drug Administration, from Schedule I to Schedule III.<\/p>\n<p>\u201cThese actions will enable more targeted, rigorous research into marijuana\u2019s safety and efficacy, expanding patients\u2019 access to treatments and empowering doctors to make better-informed healthcare decisions,\u201d Blanche wrote.<\/p>\n<p>The Drug Enforcement Administration will begin an administrative hearing on June 29 to consider the proposed reclassification.<\/p>\n<p>\u201cUnder the direction of President Donald Trump and Acting Attorney General Blanche, DEA is expeditiously moving forward with the administrative hearing process \u2014 bringing consistency and oversight to an area that has lacked both,\u201d DEA Administrator Terry Cole said in a statement.<\/p>\n<p>The order also speeds up the registration process for state-licensed operators with the DEA and confirms that researchers will not face legal consequences for using state-approved cannabis in their studies.<\/p>\n<p>In December, Trump signed an executive order directing officials to accelerate the rescheduling process as part of a broader push to expand cannabis research. At the time, he emphasized that the federal ban on marijuana would remain in place, a restriction dating back to the Marihuana Tax Act of 1937.<\/p>\n<p class=\"has-text-align-center is-style-altfont has-secondary-color has-text-color has-link-color has-xs-font-size wp-elements-a392843e06eac12cec56e735f4f8219f has-lg-margin-top\" style=\"letter-spacing:1px;text-transform:uppercase\">Scroll to continue reading<\/p>\n<p>He also warned about the risks of recreational use during the signing.<\/p>\n<p>\u201cIf it\u2019s abused, it\u2019s never safe to use powerful, controlled substances in recreational matters, and especially in this case, if you take a look, illegal and unregulated drugs, very, very bad thing,\u201d Trump said.<\/p>\n<p>Former President Joe Biden began the rescheduling process during his administration, but it was not finalized before Trump returned to office.<\/p>\n<p>Trump has also taken steps to expand drug research, including signing an executive order to accelerate studies into certain psychedelic drugs that could be used to treat mental health conditions in veterans.<\/p>\n","protected":false},"excerpt":{"rendered":"Order would shift cannabis to a lower-risk classification, expand research and provide tax relief for licensed operators KTLA5&hellip;\n","protected":false},"author":2,"featured_media":40296,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[25780,26186,25781,26187,10,65,14383,11,64,6178],"class_list":{"0":"post-40295","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-donald-trump","8":"tag-dea","9":"tag-fda","10":"tag-marijuana","11":"tag-medical-marijuana","12":"tag-potus","13":"tag-president-donald-trump","14":"tag-president-joe-biden","15":"tag-president-of-the-united-states","16":"tag-president-trump","17":"tag-todd-blanche"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@people\/116456057906390661","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/people\/wp-json\/wp\/v2\/posts\/40295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/people\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/people\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/people\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/people\/wp-json\/wp\/v2\/comments?post=40295"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/people\/wp-json\/wp\/v2\/posts\/40295\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/people\/wp-json\/wp\/v2\/media\/40296"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/people\/wp-json\/wp\/v2\/media?parent=40295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/people\/wp-json\/wp\/v2\/categories?post=40295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/people\/wp-json\/wp\/v2\/tags?post=40295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}